Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Posdinemab

Copy Product Info
😃Good
Catalog No. T80616Cas No. 2517973-04-3

Posdinemab, a humanized IgG1κ antibody, targets the microtubule-associated protein tau (MAPT) [1].

Posdinemab

Posdinemab

Copy Product Info
😃Good
Catalog No. T80616Cas No. 2517973-04-3
Posdinemab, a humanized IgG1κ antibody, targets the microtubule-associated protein tau (MAPT) [1].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$247-In Stock
5 mg$647-In Stock
10 mg$987-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:96.4% (SDS-PAGE); 95.2% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Posdinemab, a humanized IgG1κ antibody, targets the microtubule-associated protein tau (MAPT) [1].
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetMAPT
Chemical Properties
Molecular Weight145.34 kDa
Cas No.2517973-04-3
Antibody Information
IsotypeHuman IgG1 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Posdinemab | purchase Posdinemab | Posdinemab cost | order Posdinemab | Posdinemab molecular weight